000 01009 a2200277 4500
005 20250517065457.0
264 0 _c20160229
008 201602s 0 0 eng d
022 _a1756-1833
024 7 _a10.1136/bmj.h6431
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCohen, Deborah
245 0 0 _aData on trial of anticoagulant is to be reanalyzed after discovery that investigators used faulty device.
_h[electronic resource]
260 _bBMJ (Clinical research ed.)
_cDec 2015
300 _ah6431 p.
_bdigital
500 _aPublication Type: News
650 0 4 _aAtrial Fibrillation
_xblood
650 0 4 _aEquipment Failure
650 0 4 _aFactor Xa Inhibitors
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aInternational Normalized Ratio
_xinstrumentation
650 0 4 _aRivaroxaban
_xtherapeutic use
650 0 4 _aStroke
_xblood
773 0 _tBMJ (Clinical research ed.)
_gvol. 351
_gp. h6431
856 4 0 _uhttps://doi.org/10.1136/bmj.h6431
_zAvailable from publisher's website
999 _c25512635
_d25512635